Passion for Innovation. Compassion for Patients.™
Daiichi Sankyo UK Ltd.Daiichi Sankyo is proud to work in partnership with a range of NHS organisations to deliver projects with a direct and measurable benefit to patient care. The projects with which we are currently or recently involved in are listed below.
Year | Month | NHS Organisation/Third party | Brief Description of Project | Support
|
2020
| July | NHS University Hospital Birmingham NHS Foundation Trust – Heartlands Hospital | A community anticoagulant service for the frail patient population. The aim of this project to address improved diagnosis and management of Atrial Fibrillation in the frail and elderly. | £30,000 |
2019 | Oct. | NHS Staffordshire STP | To actively support general practice nurse digital champions and a GP-led digital exemplar practice team to cascade digital delivery in their practices with a focus on identifying patients currently undiagnosed with AF or lost to follow-up; engaging patients with AF and/or post-stroke to better manage their health condition(s); thus improving patient adherence to anticoagulant and other medication and improve lifestyle habits.
| £30,000 |
2019 | Sept. | Southwark CCG/ Health Innovation Network (HIN) AHSN | AF Quality Audit: This project seeks to undertake an audit of DOAC prescribing in primary care to assess whether local prescribing practice is safe and effective. | £28,500 |
2019 | Mar. | North Middlesex University Hospital NHS Trust | North Central London Anticoagulation pathway prioritisation service. The overarching aim of this project is to optimise anticoagulation services to appropriately identify and treat the anticoagulation needs of domiciliary and care home patients. | £35,429 |
2019 | Mar. | NHS Highland Trust | Evaluation of post stroke arrhythmia monitoring technologies (R-TEST) to allow appropriate use of oral anticoagulant therapy. | £28,000 |
2018 | Mar. | Bradford City Health Federation | “Non-Valvular Atrial Fibrillation Quality Improvement program (NVAFQIP)”. The overarching aim of this project is to improve the diagnosis rate and prevalence of NVAF and improve the clinical management of new and existing NVAF in primary care. Click here for Executive Summary
| £70,000 |
2017 | May. | UCL Partners Academic Health Science Network and Bayer | The project aims to support the development and confidence of GPs to initiate anticoagulation and associated service models to enable CCGs to commission primary-care anticoagulation services using GPs as prescribers. Click here for Executive Summary
| (data unavailable) |